Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hepatitis B × Tenofovir × Clear all

Phase

Status

Terminated 2 Unknown 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Recurrence 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphoma 1 Hepatitis B, Chronic 1 Hepatitis B 1 Burkitt Lymphoma 1

Interventions

entecavir 4 bicyclol 1 adefovir 1 Tenofovir 1 Telbivudine 1 Tablets 1 Radiomics 1 Nucleosides 1 Lamivudine 1 Interferons 1 Cyclophosphamide 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown

Hepatitis B, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡